medicare coverage for glp-1 drugs Poll: 1 in 8 Adults Say They've Taken a Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease CMS has announced important updates

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain

It helps address symptoms such as

Berberine patches reviewed: what science says about effectiveness, how they compare to oral supplements, side effects, and safety guidance.

FEEL THE DIFFERENCE IN DAYS, NOT WEEKS Day 13: Magnesium begins softening stool and improving motility

This state-of-the-art narrative review synthesizes current evidence from clinical trials, pharmacovigilance databases, and real-world cohorts to provide a comprehensive evaluation of the safety and tolerability of GLP-1RAs and tirzepatide